Stay updated with breaking news from Multi Center Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company plans to initiate Phase 1 ACESOT-1051 (A Multi-Center Evaluation of WEE1 Inhibitor in Patients with Advanced Solid Tumors, APR-1051)clinic...
NASHVILLE, Tenn., June 26, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced the publication of positive results from a clinical study investigating the safety and pharmaco...
New Retrospective Study Presented at AUA 2023 Reports Use of JELMYTO in Treating Patients with Upper Tract Urothelial Cancer After Complete Endoscopic Ablation ... | May 1, 2023
MARLBOROUGH, Mass. , Jan. 7, 2022 / / -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25 th North American Neuromodulation Society (NANS) annual meeting, in Orlando, Florida , on Jan.13-15, 2022. More than 20 abstracts have been accepted, including three late-breaking presentations.
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society...